ACLA News

  • American Clinical Laboratory Association Addresses Medicare Reimbursement Challenges at 2014 Annual Meeting

    March 18, 2014
    Washington, D.C. –  The American Clinical Laboratory Association (ACLA) today opened its 19th Annual Meeting entitled “Navigating the Reimbursement Maze: Challenges and Opportunities Facing Laboratories in the 21st Century,” drawing over 100 clinical laboratory professionals from across the country and featuring health policy experts that will address regulatory policy and funding challenges impacting clinical laboratories.   “As an industry, clinical labs provide the mostContinue Reading »...
  • Representative Sample of Tests No Longer Covered by TRICARE

    February 10, 2014
      Note: this is not a comprehensive list. For additional reading on this issue, please see the following articles: “DHA operations chief vows some relief from surprise lab fees,” Stars and Stripes, Feb. 6, 2014 “Some lab fees soon will be billed to Tricare patients,” Stars and Stripes, Jan. 9, 2014 Download PDF...
  • ACLA Comments on Gapfill Reconsideration Period for BRCA 1 & 2

    January 24, 2014
    January 24, 2014 Mr. Marc Hartstein, Director Hospital and Ambulatory Policy Group Center for Medicare Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland 31344 MoPathGapfillInquiries@cms.hhs.gov RE: Notification of Reconsideration Period – 2013 Gapfill Payment Amounts Dear Marc, Please accept the comments of the American Clinical Laboratory Association (“ACLA”) on the Notification of Reconsideration Period – 2013 Gapfill Payment Amounts for molecularContinue Reading »...
  • ACLA Letter to CMS Regarding Gapfill Payment Rates for BRCA1 and BRCA2 Sequencing

    December 31, 2013
    Jonathan Blum Principal Deputy Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Dear Mr. Blum: On behalf of the American Clinical Laboratory Association (“ACLA”), we are writing to express our strong objection to CMS’s recent action establishing a new reduced price for CPT code 81211 (BRCA1 and BRCA2 sequencing) as part of the gapfill price-setting process. As discussed below,Continue Reading »...
  • New Independent Study Shows Medicare Receives Lower Rates for Clinical Laboratory Services

    December 04, 2013
    Washington, D.C. — Today Avalere Health, a private data analysis firm, released a study that refutes past claims that commercial plans pay lower rates for lab services than Medicare. Instead, the study found that Medicare rates are almost always lower than average rates paid by private plans. Commissioned by the American Clinical Laboratory Association (ACLA), Avalere’s study is the most comprehensive comparison of privateContinue Reading »...
  • Statement from the American Clinical Laboratory Association on Medicare Physician Fee Schedule Final Rule

    November 27, 2013
    Today the American Clinical Laboratory Association (ACLA) commends the Centers for Medicare & Medicaid Services (CMS) for not finalizing a proposal to slash Medicare payments for anatomic pathology services which diagnose breast, colon, prostate, skin, ovarian, leukemia and other cancers. The proposal, included in the CY2014 Physician Fee Schedule Proposed Rule published in July, would have capped Medicare payments to independent laboratories to HospitalContinue Reading »...
  • Bipartisan Group of Senators Urge Medicare Officials to Drop Proposal to Cut Payments for Anatomic Pathology Services

    October 18, 2013
    Washington, D.C. — The American Clinical Laboratory Association (ACLA) praises U.S. Senators Amy Klobuchar (D-MN) and Johnny Isakson (R-GA), and 38 of their colleagues for sending a letter this week urging Centers for Medicare & Medicaid Services (CMS) Administrator Marilyn Tavenner to reconsider cuts to Medicare payments for anatomic pathology services that diagnose breast, prostate, leukemia, and other cancers. Specifically, the letter argues thatContinue Reading »...
  • 115 Members of Congress Urge Medicare Officials to Drop Proposal to Cut Medicare Payments for Pathology Services

    October 10, 2013
    Washington, D.C. — The American Clinical Laboratory Association (ACLA) applauds efforts by U.S. Congressmen Jim Gerlach (R-PA), Bill Pascrell Jr. (D-NJ) and 113 of their colleagues in the House who sent a letter yesterday to Centers for Medicare and Medicaid Services (CMS) Administrator Marilyn Tavenner requesting a withdrawal of a recommendation in the CY 2014 Medicare Physician Fee Schedule Proposed Rule to cut MedicareContinue Reading »...
  • Statement on Revised Gapfill Pricing of the Molecular Diagnostic Codes

    October 01, 2013
    Statement on Revised Gapfill Pricing of the Molecular Diagnostic Codes October 1, 2013 Washington, DC – The American Clinical Laboratory Association (ACLA) issued the following statement on the Centers for Medicare & Medicaid Services’ release of the revised gapfill pricing of the molecular diagnostic codes: “On September 30th, the Centers for Medicare & Medicaid Services released the final carrier prices for the new molecular diagnostic codes, describingContinue Reading »...
  • ACLA Submits Comments to CMS on Physician Fee Schedule, Clinical Laboratory Fee Schedule Calls For Adequate Reimbursement for Diagnostic Services

    September 03, 2013
    WASHINGTON D.C. – The American Clinical Laboratory Association (ACLA) submitted comments to the Centers for Medicare & Medicaid Services (CMS) urging the use of reimbursement policies that recognize the essential role of diagnostic services in the healthcare delivery system and protects access to these vital services for Medicare beneficiaries. In July CMS issued a rule proposing revisions to payment policies for the Medicare ProgramContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16